Clinical Approach to Heartburn
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of heartburn
Heartburn is one of the most common gastrointestinal complaints encountered in primary care, affecting approximately 20% of the adult population in Western countries on a weekly basis. In the United States alone, heartburn accounts for over 8 million physician visits annually and represents a significant burden on healthcare resources. Despite its high prevalence, heartburn remains under-recognized and under-treated, with many patients self-medicating for years before seeking medical attention. The economic impact is substantial, with annual costs exceeding $10 billion in direct medical expenses and lost productivity.
Definition
Heartburn is a burning sensation or discomfort in the retrosternal area, typically rising from the epigastrium toward the throat. It is the cardinal symptom of gastroesophageal reflux disease (GERD), caused by the retrograde movement of gastric contents into the esophagus. The sensation results from mucosal irritation by acid, pepsin, and bile, stimulating chemosensitive nociceptors in the esophageal lining.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute/Episodic | Less than 2 weeks, sporadic episodes | Dietary indiscretion, alcohol, large meals, medications | Usually self-limiting; responds to lifestyle modification and antacids |
| Frequent | 2 or more episodes per week for 4 to 8 weeks | Gastroesophageal reflux disease, hiatal hernia, obesity | Warrants empiric therapy; consider investigation if no response |
| Chronic/Refractory | Greater than 8 weeks despite treatment | Severe GERD, eosinophilic esophagitis, functional heartburn, Barrett esophagus | Requires investigation; higher risk of complications |
Classification by Character
Typical Heartburn
Description: Classic burning, rising retrosternal discomfort occurring 30 to 60 minutes after meals, worse when lying down or bending forward.
Clinical implication: Highly predictive of acid reflux; excellent response to acid suppression therapy expected.
Atypical Presentations
Description: May present as chest pressure, throat burning, globus sensation, or epigastric pain without classic burning quality.
Clinical implication: Broader differential required; cardiac causes must be excluded; may represent extraesophageal manifestations of reflux.
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Postprandial | Occurs 30 to 60 minutes after eating, especially large or fatty meals | Gastroesophageal reflux disease; transient lower esophageal sphincter relaxations |
| Nocturnal | Wakes patient from sleep; worse when supine | More severe GERD; hiatal hernia; associated with respiratory complications |
| Positional | Triggered by bending forward, stooping, or lying flat | Hiatal hernia; incompetent lower esophageal sphincter |
| Diet-related | Reproducibly triggered by specific foods (citrus, tomatoes, chocolate, coffee, alcohol) | Dietary triggers; direct mucosal irritation or sphincter relaxation |
| Exertional | Occurs during physical activity or exercise | Must exclude cardiac causes; may indicate exercise-induced reflux |
| Continuous | Persistent symptoms regardless of meals or position | Severe esophagitis; functional heartburn; eosinophilic esophagitis; malignancy |
Classification by Severity and Impact
| Severity | Frequency | Quality of Life Impact | Management Approach |
|---|---|---|---|
| Mild | Less than twice weekly | Minimal; no sleep disturbance or activity limitation | Lifestyle modification; on-demand antacids or histamine-2 receptor antagonists |
| Moderate | 2 to 7 times per week | Affects daily activities; occasional sleep disruption | Daily proton pump inhibitor therapy; lifestyle modification |
| Severe | Daily symptoms | Significant impairment; frequent sleep disturbance; affects work and social activities | Twice-daily proton pump inhibitor; investigation recommended; consider specialist referral |
Key Concept: The “Reflux Triad”
The three most common causes of chronic heartburn in primary care are:
- Gastroesophageal reflux disease (GERD) — accounts for approximately 60 to 70% of cases
- Functional heartburn — approximately 20 to 30% of refractory cases; normal acid exposure with esophageal hypersensitivity
- Eosinophilic esophagitis — increasingly recognized; particularly in younger patients with dysphagia
Understanding this triad is essential because treatment approaches differ significantly, and misdiagnosis leads to unnecessary prolonged acid suppression or missed alternative diagnoses.
Associated Symptoms and Their Significance
| Associated Symptom | Prevalence with Heartburn | Clinical Significance |
|---|---|---|
| Regurgitation | 60 to 70% | Effortless return of gastric contents; highly specific for GERD |
| Dysphagia | 30 to 40% | May indicate stricture, ring, or eosinophilic esophagitis; warrants endoscopy |
| Chest pain | 30 to 50% | Must exclude cardiac causes; non-cardiac chest pain commonly caused by GERD |
| Chronic cough | 20 to 30% | Extraesophageal manifestation; may occur without typical heartburn |
| Hoarseness | 15 to 20% | Laryngopharyngeal reflux; posterior laryngitis on examination |
| Globus sensation | 20 to 25% | Sensation of lump in throat; associated with reflux and anxiety |
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of heartburn
Heartburn results from a complex interplay between aggressive factors (gastric acid, pepsin, bile) and defensive mechanisms (lower esophageal sphincter function, esophageal clearance, mucosal resistance). Understanding these mechanisms is essential for rational therapy selection, as different conditions target different components of this balance. The esophageal mucosa, unlike the gastric mucosa, lacks significant protective mechanisms against acid exposure, making it vulnerable to injury when reflux occurs.
The Anti-Reflux Barrier
| Component | Structure | Function | Clinical Relevance |
|---|---|---|---|
| Lower Esophageal Sphincter (LES) | 3 to 4 cm segment of tonically contracted smooth muscle at gastroesophageal junction | Maintains resting pressure of 10 to 30 mmHg above intragastric pressure | Hypotensive LES (less than 10 mmHg) permits free reflux; seen in severe GERD |
| Crural Diaphragm | Right crus of diaphragm encircling the esophagus at hiatus | Provides extrinsic compression; augments LES during inspiration and straining | Disrupted in hiatal hernia; explains positional and strain-related reflux |
| Phrenoesophageal Ligament | Elastic membrane anchoring esophagus to diaphragm | Maintains position of gastroesophageal junction below diaphragm | Laxity permits hiatal hernia development |
| Angle of His | Acute angle where esophagus joins stomach | Creates a flap valve mechanism resisting reflux | Obliterated in hiatal hernia; explains increased reflux |
| Intra-abdominal Esophagus | 2 to 3 cm of esophagus below diaphragm | Exposed to positive intra-abdominal pressure, compressing lumen | Lost in hiatal hernia; LES exposed to negative intrathoracic pressure |
Primary Mechanisms of Gastroesophageal Reflux
Transient LES Relaxations (TLESRs)
Mechanism: Vagally-mediated complete relaxation of LES lasting 10 to 60 seconds, independent of swallowing
Triggered by: Gastric distension, fat ingestion, pharyngeal stimulation
Clinical relevance: Accounts for majority of reflux episodes in patients with mild to moderate GERD; target of newer therapies
Hypotensive LES
Mechanism: Resting LES pressure less than 10 mmHg permits free reflux without requiring relaxation
Caused by: Severe GERD, scleroderma, surgical damage, certain medications
Clinical relevance: Associated with more severe disease; poorer response to medical therapy; may require surgical intervention
Anatomical Disruption
Mechanism: Hiatal hernia separates LES from crural diaphragm, eliminating synergistic action
Effect: Creates acid pocket above diaphragm; impairs clearance; increases reflux episodes
Clinical relevance: Present in 50 to 90% of patients with erosive esophagitis; size correlates with severity
Esophageal Defense and Clearance Mechanisms
| Defense Mechanism | How It Works | When It Fails |
|---|---|---|
| Esophageal Peristalsis | Primary peristalsis (swallow-induced) and secondary peristalsis (distension-induced) clear refluxed material | Ineffective esophageal motility; scleroderma; severe GERD causes secondary dysmotility |
| Salivary Neutralization | Saliva (pH 7.0, contains bicarbonate) neutralizes residual acid after peristaltic clearance | Sjögren syndrome; medications causing dry mouth; during sleep (reduced salivation) |
| Epithelial Resistance | Tight junctions, mucus layer, bicarbonate secretion, and cellular buffering resist acid penetration | Prolonged acid exposure damages intercellular junctions; non-steroidal anti-inflammatory drugs |
| Tissue Repair | Rapid epithelial turnover and restitution repair minor damage | Overwhelmed by severe or prolonged acid exposure; results in erosive esophagitis |
The Postprandial Acid Pocket
Critical Concept: The Acid Pocket
After meals, a layer of unbuffered, highly acidic gastric juice (pH less than 2) accumulates at the gastroesophageal junction, sitting on top of the food bolus. This “acid pocket” is the primary source of postprandial reflux. In patients with hiatal hernia, the acid pocket is displaced above the diaphragm, making it more likely to reflux into the esophagus.
Clinical implications:
- Explains why postprandial symptoms are common despite food buffering gastric contents
- Alginate-based antacids specifically target the acid pocket
- Explains persistence of postprandial symptoms even with proton pump inhibitor therapy
How Different Conditions Cause Heartburn
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Gastroesophageal reflux disease (GERD) | Increased transient LES relaxations; impaired esophageal clearance; acid pocket reflux; with or without hiatal hernia | Acid suppression with proton pump inhibitors highly effective; lifestyle modification adjunctive |
| Hiatal hernia | LES-crural diaphragm separation; loss of angle of His; displaced acid pocket; impaired clearance due to hernial sac | Medical therapy often sufficient; large hernias may require surgical repair for refractory symptoms |
| Functional heartburn | Normal acid exposure with esophageal hypersensitivity; visceral hyperalgesia; central sensitization | Proton pump inhibitors typically ineffective; neuromodulators (tricyclic antidepressants, selective serotonin reuptake inhibitors) may help |
| Eosinophilic esophagitis | Allergic inflammation with eosinophilic infiltration; mucosal edema and sensitivity; may have concurrent reflux | Dietary elimination; topical corticosteroids; proton pump inhibitors may help in proton pump inhibitor-responsive esophageal eosinophilia |
| Medication-induced esophagitis | Direct mucosal injury from pill retention; chemical irritation (bisphosphonates, doxycycline, potassium chloride, NSAIDs) | Discontinue or modify offending medication; ensure proper pill-taking technique; short-term acid suppression for healing |
| Obesity | Increased intra-abdominal pressure; increased transient LES relaxations; higher prevalence of hiatal hernia; dietary factors | Weight loss significantly improves symptoms; may reduce need for medications; bariatric surgery may be curative |
| Pregnancy | Progesterone-mediated LES relaxation; increased intra-abdominal pressure from gravid uterus; delayed gastric emptying | Lifestyle modification first; antacids and alginates safe; histamine-2 receptor antagonists if needed; proton pump inhibitors for refractory cases |
| Scleroderma | Smooth muscle atrophy causing hypotensive LES and aperistalsis; severely impaired clearance | High-dose proton pump inhibitors essential; lifestyle measures critical; often refractory; high complication risk |
Why Nocturnal Reflux Is More Damaging
The “Nocturnal Peril”: Nighttime reflux is associated with more severe mucosal injury and complications. Several factors contribute:
- Supine position: Loss of gravity-assisted clearance; acid spreads more proximally
- Reduced salivation: Salivary flow decreases by 80% during sleep, impairing neutralization
- Absent swallowing: Primary peristalsis only occurs with swallowing; swallow frequency drops dramatically during sleep
- Prolonged acid contact time: Single reflux episode may expose mucosa for hours
- Delayed arousal: Unlike during waking hours, reflux episodes do not trigger immediate clearance behaviors
Esophageal Sensation and Pain Perception
Normal Sensation
The esophagus contains mechanoreceptors (distension), chemoreceptors (acid, temperature), and nociceptors (pain). Afferent signals travel via vagal and spinal pathways to the brainstem and cortex.
Sensitization in GERD
Chronic acid exposure causes peripheral sensitization (lowered receptor thresholds) and central sensitization (spinal and brain hyperexcitability). This explains why some patients have severe symptoms despite minimal acid exposure.
Often Overlooked: Non-Acid Reflux
Approximately 30 to 40% of patients with refractory heartburn have symptoms triggered by weakly acidic (pH 4 to 7) or non-acidic reflux. These episodes contain pepsin and bile acids that cause mucosal injury and symptom perception despite normal pH. This explains why some patients remain symptomatic on proton pump inhibitor therapy despite adequate acid suppression. Diagnosis requires combined impedance-pH monitoring, and treatment is challenging as acid suppression is ineffective.
Pathophysiology of Complications
| Complication | Mechanism | Risk Factors |
|---|---|---|
| Erosive esophagitis | Acid and pepsin overwhelm epithelial defenses; intercellular junction breakdown; mucosal erosion | Severe reflux; hiatal hernia; impaired motility; nocturnal symptoms |
| Peptic stricture | Chronic inflammation triggers fibrosis; submucosal collagen deposition; luminal narrowing | Long-standing untreated GERD; severe esophagitis; older age |
| Barrett esophagus | Intestinal metaplasia as adaptive response to chronic acid injury; squamous replaced by columnar epithelium | Male sex; white race; long duration of symptoms; obesity; hiatal hernia |
| Esophageal adenocarcinoma | Progression from Barrett esophagus through dysplasia; genetic mutations accumulate; malignant transformation | Barrett esophagus; dysplasia; long-segment Barrett; continued reflux |
3. History Taking
A comprehensive approach to eliciting the heartburn history
Red Flags — Require Urgent Evaluation
- Dysphagia — Progressive difficulty swallowing suggests stricture, ring, or malignancy
- Odynophagia — Painful swallowing indicates severe esophagitis or ulceration
- Unintentional weight loss — Greater than 5% body weight suggests malignancy
- Gastrointestinal bleeding — Hematemesis, melena, or iron deficiency anemia
- Persistent vomiting — May indicate obstruction or gastroparesis
- Age over 55 with new symptoms — Higher risk of Barrett esophagus and malignancy
- Family history of upper gastrointestinal cancer — Increases pre-test probability
- Symptoms despite adequate proton pump inhibitor therapy — Requires investigation for alternative diagnoses
Systematic History: The “BURNS” Approach
Use the mnemonic “BURNS” to ensure comprehensive heartburn history taking:
- B — Burning characteristics: Location, radiation, quality, severity (0-10 scale), and duration of each episode
- U — Unleashing factors: What triggers symptoms? Specific foods, meals, posture, time of day, stress, medications
- R — Relieving factors: What helps? Antacids, proton pump inhibitors, position changes, water, time
- N — Nocturnal and associated symptoms: Sleep disturbance, regurgitation, cough, hoarseness, chest pain, dysphagia
- S — Story evolution: Timeline of symptoms, previous investigations, treatments tried, response to therapy
Essential Questions for Each Component
Burning Characteristics
| Aspect | Questions to Ask | Clinical Significance |
|---|---|---|
| Location | “Point to where you feel the burning. Does it stay in one place or move?” | Retrosternal suggests esophageal origin; epigastric may indicate gastritis or peptic ulcer disease |
| Radiation | “Does the burning spread anywhere — to your throat, back, jaw, or arm?” | Throat radiation typical of GERD; arm or jaw radiation requires cardiac evaluation |
| Quality | “Describe the sensation — is it burning, pressure, tightness, or something else?” | Burning highly predictive of acid reflux; pressure or tightness raises cardiac concern |
| Severity | “On a scale of 0 to 10, how severe is your worst episode? Your typical episode?” | Helps assess impact and guide treatment intensity |
| Frequency | “How many days per week do you experience heartburn? How many episodes per day?” | Twice weekly or more defines GERD by consensus criteria |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Gastroesophageal reflux disease | Postprandial symptoms, regurgitation, response to antacids | “Does lying down or bending over after meals make it worse? Do you ever taste acid or food in your mouth?” |
| Functional heartburn | Symptoms despite proton pump inhibitor therapy, no erosive disease, often anxiety-associated | “Have your symptoms continued even when taking medication consistently? Do you notice symptoms worsen with stress?” |
| Eosinophilic esophagitis | Dysphagia to solids, food impaction history, atopy, younger age | “Do you ever feel food gets stuck in your chest? Have you ever had food impaction requiring emergency removal? Do you have allergies, asthma, or eczema?” |
| Peptic ulcer disease | Epigastric pain, relationship to meals, NSAID use, Helicobacter pylori risk | “Is the pain more in your upper stomach than your chest? Does eating make it better or worse? Do you take aspirin or ibuprofen regularly?” |
| Cardiac disease | Exertional symptoms, radiation to arm or jaw, risk factors, associated dyspnea | “Does the discomfort come on with physical activity? Does it spread to your arm, jaw, or back? Do you get short of breath with it?” |
| Medication-induced esophagitis | Sudden onset, pill-taking with minimal water, medications that cause esophagitis | “Have you started any new medications recently? Do you take pills with a full glass of water? Do you lie down right after taking medications?” |
| Esophageal stricture | Progressive dysphagia to solids, long-standing GERD, older age | “Over time, has it become harder to swallow solid foods? Do you have to eat slowly or cut food into small pieces?” |
| Esophageal malignancy | Progressive dysphagia, weight loss, older age, smoking history, Barrett esophagus | “Have you lost weight without trying? Is swallowing getting progressively worse over weeks to months?” |
Medication and Social History
Medications That Cause or Worsen Heartburn
- Calcium channel blockers — Relax lower esophageal sphincter
- Nitrates — Smooth muscle relaxation reduces LES pressure
- Anticholinergics — Delay gastric emptying, reduce LES tone
- Benzodiazepines — Reduce LES pressure
- Theophylline — Increases gastric acid secretion, relaxes LES
- Bisphosphonates — Direct esophageal mucosal injury
- NSAIDs — Mucosal damage, may cause ulcers
- Potassium chloride — Pill-induced esophagitis
- Doxycycline and tetracyclines — Direct mucosal irritation
- Iron supplements — Mucosal irritation if retained
- Progesterone — Relaxes LES (relevant in pregnancy)
Social and Lifestyle History
- Smoking: Reduces LES pressure, impairs clearance, increases acid secretion — ask about current use and pack-years
- Alcohol: Direct mucosal irritation, reduces LES pressure, delays gastric emptying — quantify intake
- Caffeine: May increase acid secretion and reduce LES pressure in some patients
- Obesity: Calculate BMI; central obesity particularly important; ask about weight changes
- Diet: Fatty foods, chocolate, peppermint, citrus, tomatoes, spicy foods, large meals, late eating
- Occupation: Jobs requiring bending, heavy lifting, or tight-fitting clothing
- Stress: Associated with increased symptom perception; may worsen functional heartburn
- Sleep position: Left lateral decubitus and head elevation reduce nocturnal reflux
Assessing Treatment History
| Question | Why It Matters |
|---|---|
| “What treatments have you tried? Include over-the-counter medications.” | Establishes baseline and guides next steps |
| “When you took the proton pump inhibitor, did you take it 30 to 60 minutes before breakfast?” | Incorrect timing is the most common cause of apparent proton pump inhibitor failure |
| “How many days per week did you actually take the medication?” | Non-adherence is common; proton pump inhibitors require consistent daily dosing |
| “For how long did you take the medication before deciding it didn’t work?” | Proton pump inhibitors may require 2 to 4 weeks for full effect; premature discontinuation common |
| “Did your symptoms improve at all with acid-suppressing medication?” | Partial response suggests acid-related disease; no response raises suspicion for functional heartburn |
| “Do antacids provide quick relief, even if temporary?” | Rapid antacid response strongly supports acid as the cause of symptoms |
Quality of Life Impact Assessment
Assess Functional Impact
Heartburn significantly affects quality of life. Ask about:
- Sleep: “Does heartburn wake you at night or prevent you from falling asleep?”
- Diet: “Are there foods you avoid because of symptoms? Has your eating changed?”
- Work: “Have you missed work or been less productive because of symptoms?”
- Social: “Do symptoms affect your ability to eat out or socialize?”
- Psychological: “Do you worry about what might be causing the symptoms? Do symptoms cause anxiety?”
4. Physical Examination
A systematic approach for patients presenting with heartburn
Systematic Framework: Use the “General to Specific” approach for complete examination of patients presenting with heartburn. While physical examination is often normal in uncomplicated gastroesophageal reflux disease, it is essential for identifying red flags, complications, and alternative diagnoses.
General Inspection
- Body habitus: Central obesity is a major risk factor; calculate BMI; note body fat distribution
- Nutritional status: Signs of weight loss (loose skin, temporal wasting, cachexia) suggest malignancy or severe disease
- Pallor: May indicate anemia from chronic gastrointestinal blood loss
- Respiratory distress: May suggest aspiration or severe extraesophageal manifestations
- Voice quality: Hoarseness may indicate laryngopharyngeal reflux
- Dental erosion: Visible on inspection of teeth; indicates severe chronic reflux
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Blood Pressure | Hypotension, orthostatic changes | May indicate significant gastrointestinal bleeding if present with anemia |
| Heart Rate | Tachycardia | Compensatory response to anemia or hypovolemia; also seen in anxiety |
| Respiratory Rate | Tachypnea, increased work of breathing | May indicate aspiration pneumonia or pulmonary complications of reflux |
| Oxygen Saturation | Hypoxia | Consider aspiration or chronic pulmonary complications |
| Weight | Unintentional weight loss; obesity | Weight loss is a red flag; obesity is a modifiable risk factor |
Head and Neck Examination
Oropharynx
- Dental erosion: Loss of enamel on lingual surfaces of teeth from chronic acid exposure
- Posterior pharynx: Cobblestoning or erythema may indicate laryngopharyngeal reflux
- Halitosis: May accompany reflux or indicate Zenker diverticulum
Neck
- Lymphadenopathy: Supraclavicular nodes (Virchow’s node) concerning for malignancy
- Thyroid: Goiter may cause extrinsic esophageal compression
- Jugular venous distension: Consider cardiac cause of symptoms
Chest Examination
Cardiovascular
- Heart sounds: Murmurs, gallops (S3, S4) may indicate cardiac disease as cause of chest discomfort
- Rhythm: Irregular rhythm may suggest arrhythmia causing symptoms
- Peripheral edema: Heart failure can cause hepatic congestion and reflux symptoms
Respiratory
- Inspection: Barrel chest (chronic obstructive pulmonary disease may coexist); use of accessory muscles
- Auscultation: Wheezes may indicate reflux-triggered asthma; crackles suggest aspiration or heart failure
- Percussion: Dullness may indicate pleural effusion
Abdominal Examination
Inspection
- Obesity: Central adiposity increases intra-abdominal pressure
- Distension: May indicate ascites, obstruction, or gastroparesis
- Surgical scars: Previous upper gastrointestinal surgery affects anatomy and risk
Palpation
- Epigastric tenderness: Common in gastritis and peptic ulcer disease; nonspecific in GERD
- Masses: Epigastric mass concerning for gastric malignancy
- Hepatomegaly: May indicate metastatic disease or hepatic congestion
- Ascites: Suggests advanced malignancy or liver disease
Auscultation
- Bowel sounds: Absent or high-pitched in obstruction
- Succussion splash: Splashing sound with movement; suggests gastric outlet obstruction or gastroparesis
Expected Physical Examination Findings by Etiology
| Condition | General | Head/Neck | Chest/Abdomen | Other |
|---|---|---|---|---|
| Uncomplicated GERD | Often obese; otherwise normal | Usually normal; may have dental erosion | Normal or mild epigastric tenderness | Examination typically normal |
| Laryngopharyngeal reflux | Normal habitus variable | Hoarseness; posterior pharyngeal erythema | Usually normal | Often no typical heartburn symptoms |
| Complicated GERD with stricture | May show weight loss | Normal | Normal | History of progressive dysphagia key |
| Esophageal malignancy | Cachexia; weight loss; pallor | Virchow’s node (left supraclavicular) | Hepatomegaly; ascites if metastatic | Sister Mary Joseph nodule (umbilical metastasis) |
| Peptic ulcer disease | Usually normal; pallor if bleeding | Normal | Epigastric tenderness; may have guarding if perforated | Melena on rectal examination |
| Cardiac disease | May appear distressed | Elevated JVP; carotid bruits | Abnormal heart sounds; displaced apex; edema | Diaphoresis; peripheral vascular disease signs |
| Scleroderma | Skin tightening; mask-like facies | Microstomia; telangiectasias | May have pulmonary fibrosis | Sclerodactyly; digital ulcers; Raynaud phenomenon |
| Eosinophilic esophagitis | Usually normal; often young male | Normal | Normal | May have atopic features (eczema, allergic rhinitis) |
Additional Examinations to Consider
Rectal Examination
When to perform: If anemia suspected or gastrointestinal bleeding possible
What to look for: Melena (black tarry stool) indicates upper gastrointestinal bleeding; occult blood
Skin Examination
When to perform: If systemic disease suspected
What to look for: Acanthosis nigricans (malignancy); skin tightening (scleroderma); dermatomyositis rash
Important Teaching Point
Normal examination is the rule, not the exception! The vast majority of patients with heartburn, including those with gastroesophageal reflux disease, will have completely normal physical examination findings. Physical examination in heartburn serves primarily to:
- Identify red flags suggesting serious pathology (malignancy, bleeding, stricture)
- Exclude cardiac causes of chest discomfort
- Identify modifiable risk factors (obesity)
- Detect complications of chronic reflux
- Identify systemic diseases that cause esophageal symptoms (scleroderma)
A normal examination does not exclude significant esophageal pathology; clinical history and investigations guide diagnosis.
Examination Pearls
- Always check the teeth: Dental erosion on the lingual surfaces is often the only physical sign of chronic severe reflux
- Don’t forget Virchow’s node: Left supraclavicular lymphadenopathy (Virchow’s node or Troisier’s sign) may be the first sign of gastroesophageal malignancy
- Consider cardiac examination first: In any patient with chest discomfort, ensure there are no cardiac findings before attributing symptoms to reflux
- Look for scleroderma signs: In patients with severe refractory GERD, examine the hands and face for early signs of systemic sclerosis
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
While heartburn is most commonly caused by gastroesophageal reflux disease, the differential diagnosis is broad and includes conditions ranging from benign to life-threatening. A systematic approach ensures that serious diagnoses are not missed while avoiding unnecessary investigations in straightforward cases.
Step-by-Step Approach to Heartburn Differential:
- Step 1: Exclude cardiac causes — Any chest discomfort warrants consideration of cardiac etiology, especially with risk factors
- Step 2: Identify red flags — Dysphagia, weight loss, bleeding, or age over 55 with new symptoms require investigation
- Step 3: Consider the “Big Three” esophageal causes — Gastroesophageal reflux disease, functional heartburn, and eosinophilic esophagitis
- Step 4: Review medications — Drug-induced esophagitis and medications that worsen reflux
- Step 5: Consider non-esophageal gastrointestinal causes — Peptic ulcer disease, gastritis, biliary disease
Typical Heartburn Presentation
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 60-70%) | Gastroesophageal reflux disease (GERD) | Postprandial burning; regurgitation; relief with antacids; worse lying flat | Dysphagia; bleeding; weight loss; refractory to therapy |
| COMMON (approximately 10-15%) | Functional heartburn | Typical symptoms but no response to proton pump inhibitors; normal endoscopy and pH study; often anxiety-associated | None specific; diagnosis of exclusion |
| LESS COMMON (approximately 5-10%) | Eosinophilic esophagitis | Younger patients; dysphagia to solids; food impaction; atopic history (asthma, eczema, allergies) | Food impaction requiring emergency intervention |
| LESS COMMON (approximately 5-10%) | Peptic ulcer disease | Epigastric pain; may improve or worsen with eating; NSAID or Helicobacter pylori associated | Hematemesis; melena; perforation signs |
| LESS COMMON (approximately 3-5%) | Medication-induced esophagitis | Sudden onset; temporal relationship to new medication; pill-taking with little water | Severe odynophagia; inability to swallow |
| UNCOMMON BUT SERIOUS (approximately 1-2%) | Esophageal stricture | Progressive dysphagia to solids; long-standing GERD history; older age | Complete dysphagia; weight loss |
| UNCOMMON BUT SERIOUS (less than 1%) | Esophageal or gastric malignancy | Progressive dysphagia; unintentional weight loss; older age; smoking history | Cachexia; lymphadenopathy; iron deficiency anemia |
Atypical or Chest Pain Presentation
Critical Rule
When heartburn presents as chest pain or pressure, always consider and appropriately exclude cardiac causes before attributing symptoms to reflux, especially in patients with cardiovascular risk factors.
| Probability | Condition | Key Differentiating Features | Action Required |
|---|---|---|---|
| MUST EXCLUDE | Acute coronary syndrome | Exertional; radiation to arm or jaw; diaphoresis; dyspnea; risk factors (diabetes, hypertension, smoking, family history) | ECG; troponin; cardiology evaluation if any suspicion |
| MUST EXCLUDE | Stable angina | Predictably exertional; relieved by rest or nitrates; duration typically less than 20 minutes | Stress testing; cardiology referral |
| COMMON | Non-cardiac chest pain from GERD | Postprandial; positional; associated heartburn or regurgitation; responds to proton pump inhibitors | Trial of proton pump inhibitor therapy; cardiac workup if risk factors |
| LESS COMMON | Esophageal motility disorders | Dysphagia to both solids and liquids; intermittent chest pain; regurgitation of undigested food | Esophageal manometry |
| LESS COMMON | Musculoskeletal chest pain | Reproducible with palpation; worsened by movement or position; localized tenderness | Clinical diagnosis; trial of analgesics |
Anatomical Approach to Differential Diagnosis
Esophageal
Gastroesophageal reflux disease
Functional heartburn
Eosinophilic esophagitis
Esophageal stricture
Esophageal malignancy
Medication-induced esophagitis
Infectious esophagitis
Esophageal motility disorders
Gastric
Peptic ulcer disease
Gastritis (Helicobacter pylori, NSAID, stress)
Gastroparesis
Gastric malignancy
Hiatal hernia
Cardiac
Acute coronary syndrome
Stable angina
Pericarditis
Heart failure
Arrhythmias
Other
Biliary colic or cholecystitis
Pancreatitis
Musculoskeletal chest wall pain
Pulmonary embolism
Pneumonia
Anxiety and panic disorder
Drug-Induced Heartburn and Esophagitis
| Drug or Drug Class | Mechanism | Characteristics | Management |
|---|---|---|---|
| Bisphosphonates (alendronate, risedronate) | Direct mucosal injury; pill retention in esophagus | Severe retrosternal pain; odynophagia; ulceration typically mid-esophagus | Take with full glass of water; remain upright 30-60 minutes; consider IV formulation |
| NSAIDs (ibuprofen, naproxen, aspirin) | Prostaglandin inhibition; direct mucosal toxicity; impairs healing | Epigastric pain; may cause ulcers anywhere in upper GI tract | Discontinue if possible; add proton pump inhibitor if NSAID essential |
| Doxycycline and tetracyclines | Acidic pH causes direct mucosal injury if pill retained | Sudden onset odynophagia; mid-esophageal ulceration; often in young patients | Take with full glass of water; avoid lying down; consider alternative antibiotic |
| Potassium chloride | Hyperosmolar injury; direct caustic effect | Severe pain; can cause stricture; often in elderly with motility issues | Use liquid formulation; ensure adequate hydration; take with meals |
| Iron supplements | Direct mucosal irritation; oxidative injury | Epigastric discomfort; nausea; constipation | Take with food; consider alternate-day dosing; IV iron if severe intolerance |
| Calcium channel blockers | Relax lower esophageal sphincter smooth muscle | Worsen existing reflux; postprandial symptoms | Consider alternative antihypertensive if GERD severe |
| Nitrates | Smooth muscle relaxation reduces LES pressure | Worsen reflux; may cause or exacerbate heartburn | Optimize GERD treatment; timing of nitrate administration |
| Anticholinergics | Delay gastric emptying; reduce LES tone; decrease salivation | Multiple mechanisms worsen reflux | Review necessity; consider alternatives; optimize GERD treatment |
| Quinidine | Direct esophageal mucosal injury | Pill-induced esophagitis | Ensure adequate water intake; consider alternative |
Differential Diagnosis of Refractory Heartburn
When Proton Pump Inhibitor Therapy Fails
Approximately 30-40% of patients have persistent symptoms despite proton pump inhibitor therapy. Consider these causes:
- Non-adherence or incorrect timing: Most common cause; proton pump inhibitors must be taken 30-60 minutes before meals
- Functional heartburn: Normal acid exposure with visceral hypersensitivity
- Weakly acidic or non-acid reflux: Symptoms from reflux with pH greater than 4
- Eosinophilic esophagitis: Especially if dysphagia present
- Bile reflux: May occur post-cholecystectomy or with duodenogastric reflux
- Incorrect diagnosis: Symptoms may not be reflux-related
- Rapid proton pump inhibitor metabolism: CYP2C19 ultra-rapid metabolizers may need higher doses
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Burning after meals, relief with antacids | Gastroesophageal reflux disease | Trial of proton pump inhibitor therapy |
| Dysphagia to solids, food impaction, young atopic patient | Eosinophilic esophagitis | Upper endoscopy with biopsies |
| Symptoms despite adequate proton pump inhibitor therapy, anxiety | Functional heartburn | Endoscopy; pH-impedance monitoring |
| Progressive dysphagia, weight loss, older patient | Esophageal malignancy or stricture | Urgent upper endoscopy |
| Sudden onset after starting new medication | Medication-induced esophagitis | Identify and stop offending drug; supportive care |
| Epigastric pain, NSAID use, Helicobacter pylori risk factors | Peptic ulcer disease | Helicobacter pylori testing; consider endoscopy |
| Exertional chest discomfort, cardiovascular risk factors | Cardiac disease | ECG; troponin if acute; cardiology evaluation |
| Immunocompromised patient, odynophagia | Infectious esophagitis (Candida, HSV, CMV) | Upper endoscopy with brushings and biopsies |
| Dysphagia to solids AND liquids, regurgitation of undigested food | Esophageal motility disorder (achalasia) | Barium swallow; esophageal manometry |
| Skin tightening, Raynaud phenomenon, severe reflux | Scleroderma esophagus | Rheumatology referral; aggressive acid suppression |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The diagnosis of uncomplicated gastroesophageal reflux disease is primarily clinical, and most patients can be treated empirically without investigations. However, investigations are essential when red flags are present, when symptoms are atypical, or when empiric therapy fails. A stepwise approach optimizes resource utilization while ensuring serious pathology is not missed.
Indications for Investigation:
- Presence of any red flag symptoms (dysphagia, weight loss, bleeding, anemia)
- Age over 55 years with new-onset symptoms
- Symptoms refractory to adequate proton pump inhibitor therapy (8 weeks)
- Atypical symptoms or diagnostic uncertainty
- Consideration of anti-reflux surgery
- Long-standing symptoms (greater than 5-10 years) to screen for Barrett esophagus
Baseline Investigations for All Patients with Red Flags
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Screen for anemia from occult bleeding | Low hemoglobin; microcytic indices suggesting iron deficiency | Iron deficiency anemia in adults requires GI evaluation |
| Iron studies | Confirm iron deficiency if anemia present | Low ferritin; low serum iron; elevated total iron-binding capacity | Ferritin less than 30 ng/mL confirms deficiency; less than 100 ng/mL suspicious in inflammation |
| Basic metabolic panel | Assess hydration; exclude metabolic causes | Electrolyte abnormalities if vomiting; renal function | Baseline before proton pump inhibitor therapy; monitor magnesium with long-term use |
| Helicobacter pylori testing | Identify treatable cause of dyspepsia | Positive urea breath test, stool antigen, or serology | Stop proton pump inhibitors 2 weeks before breath test or stool antigen |
| ECG | Exclude cardiac cause if chest pain component | Ischemic changes; arrhythmia | Low threshold in patients with cardiovascular risk factors |
Upper Endoscopy (Esophagogastroduodenoscopy)
The Gold Standard for Structural Evaluation
Upper endoscopy allows direct visualization of the esophageal mucosa, identification of complications, and tissue sampling for histology.
Indications for Upper Endoscopy
Definite Indications
- Dysphagia or odynophagia
- Unintentional weight loss
- Evidence of GI bleeding (hematemesis, melena, iron deficiency anemia)
- Persistent vomiting
- Palpable mass or lymphadenopathy
- Age over 55 with new-onset symptoms
Consider Endoscopy
- Symptoms refractory to 8 weeks of proton pump inhibitor therapy
- Recurrent symptoms after stopping proton pump inhibitor
- Long-standing symptoms (greater than 5 years) for Barrett screening
- Prior to anti-reflux surgery
- Suspected eosinophilic esophagitis
- Atypical symptoms with diagnostic uncertainty
Endoscopic Findings and Interpretation
| Finding | Description | Clinical Significance | Action |
|---|---|---|---|
| Normal esophagus | No visible mucosal abnormality | Does not exclude GERD; 50-70% of GERD patients have normal endoscopy (non-erosive reflux disease) | Empiric therapy; consider pH monitoring if refractory |
| Erosive esophagitis (Los Angeles Grade A-D) | Mucosal breaks: A (less than 5mm), B (greater than 5mm), C (continuous between folds), D (greater than 75% circumference) | Confirms GERD; severity guides treatment duration | Proton pump inhibitor therapy 8 weeks; repeat endoscopy for Grade C/D to confirm healing |
| Barrett esophagus | Salmon-colored mucosa extending above gastroesophageal junction | Intestinal metaplasia; premalignant condition; requires surveillance | Biopsies to confirm; surveillance program; proton pump inhibitor therapy |
| Peptic stricture | Smooth, circumferential narrowing typically at gastroesophageal junction | Complication of chronic GERD; causes dysphagia | Dilation; long-term proton pump inhibitor; biopsies to exclude malignancy |
| Esophageal rings (Schatzki ring) | Thin circumferential mucosal ring at squamocolumnar junction | Causes intermittent solid food dysphagia | Dilation if symptomatic |
| Eosinophilic esophagitis features | Rings (trachealization), furrows, white exudates, stricture, narrow caliber | Requires biopsies for diagnosis (greater than 15 eosinophils per high-power field) | Multiple biopsies from proximal and distal esophagus; dietary and medical therapy |
| Hiatal hernia | Gastric cardia above diaphragmatic hiatus | Common; contributes to reflux; size correlates with severity | Medical management; surgical repair if large and symptomatic |
| Mass or ulcer | Irregular mass, deep ulceration, or suspicious lesion | Requires biopsy to exclude malignancy | Multiple biopsies; staging if malignancy confirmed |
Ambulatory Reflux Monitoring
24-48 Hour pH Monitoring
- Method: Catheter-based or wireless capsule (Bravo) measures esophageal acid exposure
- Key metric: Acid exposure time (AET); abnormal if greater than 6% of total time
- Indications: Refractory symptoms; atypical symptoms; pre-operative evaluation
- Timing: Off proton pump inhibitor (7 days) to document reflux; on proton pump inhibitor to assess treatment adequacy
Combined pH-Impedance Monitoring
- Advantage: Detects all reflux episodes regardless of pH (acid, weakly acidic, non-acid)
- Key metrics: Total reflux episodes; symptom association probability (SAP); symptom index (SI)
- Best for: Patients with refractory symptoms on proton pump inhibitor therapy
- Interpretation: SAP greater than 95% or SI greater than 50% indicates positive symptom-reflux association
Esophageal Manometry
| Indication | What It Assesses | Key Findings |
|---|---|---|
| Pre-operative evaluation | LES pressure and relaxation; esophageal body peristalsis | Ensures adequate peristalsis for fundoplication; identifies motility disorders |
| Dysphagia evaluation | Esophageal motility patterns | Achalasia (absent peristalsis, incomplete LES relaxation); other motility disorders |
| Suspected motility disorder | Peristaltic patterns; LES function | Diffuse esophageal spasm; jackhammer esophagus; ineffective esophageal motility |
| Positioning pH probe | Locates LES for accurate probe placement | Ensures pH sensor positioned 5 cm above LES |
Barium Swallow and Upper GI Series
When to Use Barium Studies
While endoscopy is preferred for mucosal evaluation, barium swallow has specific advantages:
- Anatomical assessment: Better for hiatal hernia size, paraesophageal hernia, esophageal diverticula
- Dysphagia workup: Initial test when achalasia or motility disorder suspected (bird’s beak appearance)
- Stricture evaluation: Defines length and degree of narrowing before dilation
- Post-surgical anatomy: Evaluates fundoplication integrity; identifies recurrent hernia
- When endoscopy is contraindicated or refused
Targeted Investigations by Suspected Etiology
If Suspecting Eosinophilic Esophagitis
Required Tests
- Upper endoscopy with biopsies: At least 6 biopsies from proximal and distal esophagus
- Histology: Greater than 15 eosinophils per high-power field diagnostic
Additional Considerations
- Allergy testing: Skin prick testing or specific IgE for food allergens
- Trial of proton pump inhibitor: To exclude proton pump inhibitor-responsive esophageal eosinophilia
If Suspecting Cardiac Disease
First-Line Tests
- ECG: Ischemic changes, arrhythmia
- Troponin: If acute presentation concerning for acute coronary syndrome
Further Evaluation
- Stress testing: Exercise ECG, stress echocardiography, or nuclear perfusion imaging
- Coronary angiography: If non-invasive testing positive or high clinical suspicion
If Suspecting Helicobacter pylori-Related Disease
| Test | Sensitivity/Specificity | Advantages | Limitations |
|---|---|---|---|
| Urea breath test | Greater than 95% / greater than 95% | Non-invasive; can confirm eradication | Must stop proton pump inhibitor 2 weeks prior |
| Stool antigen test | Greater than 95% / greater than 95% | Non-invasive; widely available; confirms eradication | Must stop proton pump inhibitor 2 weeks prior |
| Serology | 85-90% / 80-90% | Not affected by proton pump inhibitor use; inexpensive | Cannot distinguish active from past infection; cannot confirm eradication |
| Endoscopic biopsy (rapid urease test) | Greater than 90% / greater than 95% | Immediate result; can be done during diagnostic endoscopy | Invasive; false negatives if recent proton pump inhibitor or antibiotic use |
Empiric Treatment Trials as Diagnostic Tools
The Proton Pump Inhibitor Trial
In patients with typical heartburn symptoms without red flags, an empiric trial of proton pump inhibitor therapy serves as both treatment and diagnostic test.
- Protocol: Standard-dose proton pump inhibitor (e.g., omeprazole 20 mg, esomeprazole 20 mg) once daily, 30-60 minutes before breakfast
- Duration: 8 weeks for adequate trial
- Interpretation: Greater than 50% symptom improvement suggests acid-related disease
- Sensitivity: 75-80% for GERD diagnosis
- Specificity: 55-65% (some non-GERD conditions also respond)
- If no response: Optimize therapy (timing, adherence, dose increase) before concluding proton pump inhibitor failure
Optimizing the Proton Pump Inhibitor Trial
| Step | Action | Rationale |
|---|---|---|
| 1. Verify timing | Take 30-60 minutes before first meal of the day | Proton pump inhibitors only block actively secreting proton pumps; meal stimulates secretion |
| 2. Confirm adherence | Daily dosing for full 8 weeks | Intermittent dosing is ineffective; takes time to achieve maximal acid suppression |
| 3. Consider dose escalation | Increase to twice daily (before breakfast and before dinner) if inadequate response | Some patients require higher doses; nocturnal symptoms may need evening dose |
| 4. Switch proton pump inhibitor | Try alternative proton pump inhibitor if one fails | Pharmacokinetic differences; CYP2C19 metabolism varies |
| 5. Add adjunctive therapy | Consider adding bedtime histamine-2 receptor antagonist or alginate | Addresses nocturnal acid breakthrough; targets acid pocket |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Chest pain with exertional component, diaphoresis, dyspnea, or radiation to arm/jaw | EMERGENT | ECG and troponin immediately; treat as acute coronary syndrome until proven otherwise |
| Hematemesis, melena, or signs of significant GI bleeding | EMERGENT | IV access; fluid resuscitation; type and screen; urgent gastroenterology consultation; urgent endoscopy |
| Complete dysphagia (unable to swallow saliva) | EMERGENT | NPO; urgent endoscopy for food impaction or obstruction |
| Severe odynophagia with inability to maintain hydration | URGENT | IV fluids; endoscopy within 24-48 hours; consider infectious or pill-induced esophagitis |
| Progressive dysphagia with weight loss | URGENT | Expedited endoscopy within 2 weeks to exclude malignancy |
| New heartburn in patient over 55 years | URGENT | Endoscopy before or concurrent with empiric therapy |
| Typical heartburn without red flags in patient under 55 | ROUTINE | Empiric proton pump inhibitor trial; lifestyle modification; investigate if no response in 8 weeks |
| Intermittent mild heartburn, responsive to antacids | ROUTINE | Lifestyle modification; on-demand antacid or histamine-2 receptor antagonist therapy |
Step 2: Classify the Presentation
Typical Heartburn
Features: Retrosternal burning, postprandial, relief with antacids, regurgitation
Action: Empiric proton pump inhibitor trial if no red flags
Atypical Presentation
Features: Chest pain, throat symptoms, cough, globus without classic burning
Action: Exclude cardiac disease; consider proton pump inhibitor trial; lower threshold for investigation
Red Flag Presentation
Features: Dysphagia, weight loss, bleeding, age over 55 with new symptoms
Action: Endoscopy required before or concurrent with therapy
Step 3: Follow the Appropriate Algorithm
Algorithm A: Typical Heartburn Without Red Flags
| Step | Action | If Successful | If Unsuccessful |
|---|---|---|---|
| 1 | Lifestyle modification plus standard-dose proton pump inhibitor once daily for 8 weeks | Continue proton pump inhibitor; attempt step-down to on-demand or histamine-2 receptor antagonist | Proceed to Step 2 |
| 2 | Optimize proton pump inhibitor: verify timing (30-60 min before breakfast), confirm adherence, increase to twice daily | Continue optimized therapy; attempt gradual dose reduction | Proceed to Step 3 |
| 3 | Upper endoscopy to evaluate for complications, Barrett esophagus, eosinophilic esophagitis, or alternative diagnosis | Treat identified pathology | Proceed to Step 4 if endoscopy normal or shows only non-erosive disease |
| 4 | Ambulatory pH-impedance monitoring (on proton pump inhibitor therapy) | If abnormal acid exposure: consider surgical referral; if symptom-reflux correlation positive: reflux hypersensitivity | If normal: functional heartburn; consider neuromodulator therapy |
Algorithm B: Heartburn with Dysphagia
| Dysphagia Type | Most Likely Causes | Initial Investigation | Management |
|---|---|---|---|
| Solids only, intermittent | Schatzki ring; eosinophilic esophagitis; early stricture | Upper endoscopy with biopsies | Dilation for ring/stricture; dietary/steroid therapy for eosinophilic esophagitis |
| Solids only, progressive | Peptic stricture; malignancy | Urgent upper endoscopy with biopsies | Dilation plus proton pump inhibitor for benign stricture; oncology referral for malignancy |
| Solids AND liquids | Motility disorder (achalasia); severe stricture | Barium swallow followed by esophageal manometry | Motility-directed therapy (pneumatic dilation, myotomy for achalasia) |
| With food impaction history | Eosinophilic esophagitis; Schatzki ring | Upper endoscopy with multiple esophageal biopsies | Treat underlying cause; consider prophylactic dilation |
Algorithm C: Suspected Extraesophageal Reflux
| Presentation | Evaluation | Management Approach |
|---|---|---|
| Chronic cough with heartburn | Chest X-ray; consider pulmonary function tests; proton pump inhibitor trial | Twice-daily proton pump inhibitor for 8-12 weeks; if no response, investigate other causes (asthma, upper airway cough syndrome) |
| Chronic cough WITHOUT heartburn | Evaluate for other causes first (asthma, upper airway cough syndrome, angiotensin-converting enzyme inhibitors) | Proton pump inhibitor trial only after ruling out more common causes; lower success rate |
| Hoarseness or throat symptoms | Laryngoscopy by ENT; evaluate for laryngopharyngeal reflux signs | Twice-daily proton pump inhibitor for 2-3 months; dietary and behavioral modifications; manage expectations (often partial response) |
| Asthma with reflux symptoms | Optimize asthma management first; proton pump inhibitor trial | Proton pump inhibitors may improve asthma control in some patients; more effective if reflux symptoms present |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient reports proton pump inhibitor “doesn’t work” | Verify timing (30-60 min before meal) and adherence (daily dosing) | If timing/adherence optimal: increase to twice daily; if still no response after 8 weeks: endoscopy |
| Endoscopy shows erosive esophagitis Grade C or D | Continue proton pump inhibitor twice daily for 8 weeks | Repeat endoscopy to confirm healing; long-term maintenance proton pump inhibitor therapy |
| Barrett esophagus found on endoscopy | Continue proton pump inhibitor therapy; review histology for dysplasia | Enroll in surveillance program; frequency depends on dysplasia status |
| Eosinophilic esophagitis diagnosed | Trial of high-dose proton pump inhibitor for 8 weeks to assess proton pump inhibitor-responsive eosinophilia | If responsive: maintain proton pump inhibitor; if not: dietary elimination or topical corticosteroids |
| Normal endoscopy but symptoms persist on proton pump inhibitor | Continue proton pump inhibitor; arrange pH-impedance monitoring | Based on results: surgical referral if abnormal reflux; neuromodulator if functional heartburn |
| Patient wants to stop long-term proton pump inhibitor | Discuss indication; if appropriate, taper gradually (do not stop abruptly) | Step down to lower dose, then to histamine-2 receptor antagonist or on-demand; monitor for symptom recurrence |
| Patient asks about anti-reflux surgery | Ensure objective documentation of reflux (pH study); esophageal manometry to assess motility | Surgical referral if: confirmed GERD, responds to proton pump inhibitor but prefers surgery, adequate esophageal motility |
| Pregnant patient with heartburn | Lifestyle modifications first (small meals, elevate head, avoid late eating) | Step-up: antacids/alginates → histamine-2 receptor antagonists → proton pump inhibitors if needed; all considered acceptably safe |
| Elderly patient with new heartburn | Lower threshold for endoscopy (increased malignancy risk) | Endoscopy recommended before or concurrent with empiric therapy if age over 55 with new symptoms |
| Patient concerned about long-term proton pump inhibitor risks | Review indication and confirm ongoing need; discuss actual versus perceived risks | If strong indication: reassure and continue; ensure adequate calcium/vitamin D; monitor magnesium if prolonged use |
Troubleshooting Refractory Heartburn
Systematic Approach to Treatment Failure
When heartburn persists despite proton pump inhibitor therapy, work through this checklist:
- Is the timing correct? Proton pump inhibitors must be taken 30-60 minutes before meals
- Is adherence adequate? Daily dosing required; intermittent use is ineffective
- Was the duration sufficient? Full 8 weeks needed for adequate trial
- Has dose been optimized? Consider twice-daily dosing before declaring failure
- Is the diagnosis correct? Consider endoscopy to identify alternative pathology
- Is there weakly acidic or non-acid reflux? pH-impedance monitoring required to detect
- Could this be functional heartburn? Normal acid exposure with visceral hypersensitivity
- Are there contributing factors? Obesity, dietary triggers, medications, hiatal hernia
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Timing is everything: The single most common reason for proton pump inhibitor “failure” is incorrect timing. Proton pump inhibitors must be taken 30-60 minutes before the first meal of the day to be effective. Taking them at bedtime or with meals dramatically reduces efficacy.
Normal endoscopy does not exclude GERD: Up to 70% of patients with gastroesophageal reflux disease have non-erosive reflux disease with a completely normal-appearing esophagus on endoscopy. A normal endoscopy confirms absence of complications but does not rule out reflux.
Think eosinophilic esophagitis in young patients with dysphagia: Any patient under 50 with solid food dysphagia or food impaction history should have esophageal biopsies taken during endoscopy, even if the mucosa appears normal. Eosinophilic esophagitis is increasingly common.
Response to antacids is diagnostically useful: Rapid (within minutes) relief of symptoms with antacids strongly suggests acid as the cause. This simple observation has high positive predictive value for acid-related disease.
Weight loss works: In overweight and obese patients, even modest weight loss (5-10% of body weight) can significantly improve or resolve heartburn symptoms. This should be emphasized as a first-line intervention.
Nocturnal symptoms predict complications: Patients with nocturnal heartburn or regurgitation have more severe disease, higher rates of erosive esophagitis, and increased risk of Barrett esophagus. These patients warrant more aggressive therapy and lower threshold for investigation.
Alarm symptoms mandate investigation regardless of age: While age over 55 is an independent indication for endoscopy, dysphagia, weight loss, bleeding, or anemia require investigation at any age. Never dismiss red flags in a young patient.
The proton pump inhibitor trial is imperfect: While useful, the proton pump inhibitor trial has only 75-80% sensitivity for GERD. A negative response does not exclude reflux disease, and a positive response can occur in non-GERD conditions. Use clinical context.
Critical Pitfalls to Avoid
Assuming all chest discomfort is reflux: Heartburn can mimic cardiac pain and vice versa. In any patient with cardiovascular risk factors or atypical features, perform appropriate cardiac evaluation before attributing symptoms to GERD. Missing acute coronary syndrome can be fatal.
Declaring proton pump inhibitor failure too quickly: Ensure correct timing, adequate adherence, and full 8-week duration before concluding that proton pump inhibitor therapy has failed. Many apparent failures are actually adherence or timing issues.
Missing medication-induced esophagitis: Always take a detailed medication history. Bisphosphonates, doxycycline, potassium chloride, and NSAIDs can cause severe esophageal injury. The temporal relationship to starting a new medication is the key clue.
Forgetting to biopsy for eosinophilic esophagitis: Eosinophilic esophagitis can have subtle or absent endoscopic findings. If a patient has dysphagia or food impaction history, always obtain esophageal biopsies even if the mucosa looks normal.
Ignoring the importance of lifestyle modification: Proton pump inhibitors are effective, but lifestyle changes (weight loss, dietary modification, head of bed elevation, avoiding late meals) are underutilized and can reduce or eliminate medication need.
Stopping proton pump inhibitors abruptly: Abrupt discontinuation after long-term use can cause rebound acid hypersecretion and symptom flare. Taper gradually when discontinuing chronic therapy.
Over-investigating low-risk patients: Young patients with typical symptoms, no red flags, and good response to therapy do not need routine endoscopy. Reserve investigations for appropriate indications to avoid unnecessary procedures and costs.
Attributing refractory symptoms to inadequate acid suppression alone: When symptoms persist despite optimized proton pump inhibitor therapy, consider functional heartburn, weakly acidic reflux, or incorrect diagnosis. More acid suppression is not always the answer.
Key Takeaways
- Heartburn is one of the most common symptoms in primary care, affecting approximately 20% of adults weekly, but requires careful evaluation to distinguish benign from serious causes.
- The diagnosis of uncomplicated gastroesophageal reflux disease is clinical; most patients without red flags can be treated empirically with a proton pump inhibitor trial without initial investigation.
- Red flag symptoms (dysphagia, weight loss, bleeding, anemia, age over 55 with new symptoms) mandate endoscopic evaluation before or concurrent with therapy.
- Proton pump inhibitor timing is critical — taking the medication 30-60 minutes before the first meal of the day is essential for efficacy. Incorrect timing is the most common cause of apparent treatment failure.
- Normal endoscopy does not exclude GERD; up to 70% of patients have non-erosive reflux disease with no visible mucosal abnormality.
- Consider eosinophilic esophagitis in any patient with dysphagia or food impaction, especially younger patients with atopic history. Always obtain esophageal biopsies when this diagnosis is suspected.
- Functional heartburn (normal acid exposure with visceral hypersensitivity) accounts for 20-30% of refractory cases and does not respond to acid suppression. Neuromodulators may be helpful.
- Lifestyle modifications including weight loss, dietary changes, head of bed elevation, and avoiding late meals are effective and underutilized interventions.
- When proton pump inhibitor therapy fails, systematically evaluate timing, adherence, dose optimization, and consider pH-impedance monitoring to characterize the problem before escalating therapy.
- Always consider cardiac disease in the differential diagnosis of chest discomfort, even when symptoms seem typical for reflux, particularly in patients with cardiovascular risk factors.
Quick Reference Algorithm
Systematic Approach to Heartburn:
- Assess urgency: Identify red flags; exclude cardiac disease if chest pain present
- Classify presentation: Typical heartburn, atypical symptoms, or red flag presentation
- Investigate if indicated: Endoscopy for red flags, age over 55, or refractory symptoms
- Initiate empiric therapy: Lifestyle modification plus proton pump inhibitor 30-60 minutes before breakfast
- Optimize before escalating: Verify timing and adherence; increase to twice daily if needed
- Investigate refractory cases: Endoscopy, then pH-impedance monitoring if endoscopy non-diagnostic
- Consider alternative diagnoses: Functional heartburn, eosinophilic esophagitis, non-acid reflux if proton pump inhibitor-refractory
- Reassess periodically: Attempt step-down therapy; address modifiable risk factors; ensure ongoing indication for treatment